Fagron acquires PHARMAVIT
Fagron agreed to acquire PHARMAVIT. Reported deal value: €68M. Status: Completed. Sector: Nutraceuticals. Target headquarters context: 4761 Rm, Zevenbergen, Netherlands.
This page summarizes publicly available information about the transaction as of 2026-02-26. Figures and status may change as filings and press coverage update.
Nazareth /Rotterdam , 26 February 2026 – 6:30PM Fagron completes strategic acquisition of Pharmavit Europe , strengthening its leadership in high ‑ growth nutraceutical ingredients across EMEA Fagron , the leading global player in pharmaceutical compounding, announces that it has completed the acquisition of Pharmavit Europe , a leading Europe an distributor of nutraceutical raw materials based in the Netherlands
Deal timeline
This transaction is classified in Nutraceuticals with a reported deal value of €68M. Figures and status may change as sources update.